NOV 03, 2016 6:00 AM PDT

Mutation Detection Simplified: From Liquid Biopsy in clinical oncology to the detection of Drug Resistance Associated Mutations in virology

Speakers

Abstract

Sanger sequencing and polymerase chain reaction (PCR) methods have been the standard molecular methods in clinical diagnostics for decades.  Next-Generation Sequencing (NGS) technology revolutionized the field of genomics, transcriptomics and metagenomics and is now swiftly becoming a routine method in different areas of clinical diagnostics [1,2].

Vela Diagnostics developed an integrated automated multi-purpose Sentosa® workflow, which consists of:

  1. A customized robotic liquid handling system for nucleic acid extraction, PCR set-up and/ or NGS library preparation (Sentosa® SX101) 
  2. Instruments for real-time PCR or template preparation and deep sequencing
  3. Kits for nucleic acid extraction, real-time PCR-based tests, NGS library preparation assays and reagents for deep sequencing
  4. Flexible and easily customizable assay specific applications
  5. Data analysis and reporting software

The combined automated qPCR & NGS Sentosa® workflow is a reliable and efficient in-vitro diagnostics tool for the detection and/or quantitation of a wide range of bacterial and viral pathogens as well as gene mutations. The unique ability of the Sentosa workflow is to provide complete & relevant information to aid clinical decision-making and patient management. 
 
We’ll look at how this single, rapid workflow may be applied to HIV and HCV, delivering accurate genotyping information and in the detection of drug-resistant mutations.
 
We’ll also see how this workflow is able to deliver actionable oncology results using liquid biopsy samples (cfDNA) with utility in NSCLC, CRC, and BRAF mutation detection.
 


Show Resources
You May Also Like
MAY 11, 2021 10:00 AM PDT
C.E. CREDITS
MAY 11, 2021 10:00 AM PDT
Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
JUN 09, 2021 7:00 AM PDT
C.E. CREDITS
JUN 09, 2021 7:00 AM PDT
Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
APR 01, 2021 8:00 AM PDT
C.E. CREDITS
APR 01, 2021 8:00 AM PDT
Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
MAR 16, 2021 10:00 AM PDT
C.E. CREDITS
MAR 16, 2021 10:00 AM PDT
Date: March 16, 2021 Time: 10:00am (PST) Scientific progress and breakthroughs today are often too expensive for most institutions to acquire. Each year, the National Institutes of Health (N...
APR 21, 2021 10:00 AM PDT
C.E. CREDITS
APR 21, 2021 10:00 AM PDT
Date: April 21, 2021 Time: 10:00am (PDT), 1:00pm (EDT) Serological testing for SARS-CoV-2 has been steadily adopted into clinical practice over the course of this pandemic. In this webinar,...
MAR 18, 2021 8:00 AM PDT
C.E. CREDITS
MAR 18, 2021 8:00 AM PDT
DATE: March 18, 2021 TIME: 8:00am PDT Sequencing of bulk cells, single cells, and nuclei is opening doors in the understanding of complex biological processes....
NOV 03, 2016 6:00 AM PDT

Mutation Detection Simplified: From Liquid Biopsy in clinical oncology to the detection of Drug Resistance Associated Mutations in virology


Specialty

Gene Expression

Research And Development

Dna

Big Data

Cancer Research

Tumor

Biomarkers

Cancer

Oncology

Earth Science

Gene Sequencing

University

Drug Discovery

Mass Cytometry

Cell Culture

Geography

Asia50%

Europe50%

Registration Source

Website Visitors100%

Job Title

Student50%

Medical Laboratory Technician50%

Organization

Manufacturer - Other50%

Academic Institution50%


Show Resources
Loading Comments...
Show Resources
Attendees
  • See more